2-((Tetrahydro-2H-pyran-4-yl)oxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 250mg

Éther monométhylique de tripropylène glycol, min 97 %, pour la synthèse, 2,5 l, emballage plastique.

Ester éthylique d'acide L(-)-lactique, 96 % min., 5 l, emballage plastique.

N-(3-methylenecyclohexyl)-, 1,1-dimethylethyl ester, 95.0%, 1g

2-Chloro-5-(3-ethoxycarbonylbenzoyl)pyridine, 97.0%, 1g

5-Amino-1-(3-fluoro-4-methyl-phenyl)-3-methyl-1H-pyrazole-4-carbonitrile, 95.0%, 1g

3-Methoxy-1-methyl-1H-pyrazole, 97%, 250mg

ethyl 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylate, 95.0%, 250mg

3-Cyano-4-oxo-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100g

N-methyl-4-morpholin-4-ylbutan-1-amine, 95.0%, 250mg

2-Chloro-4-(trifluoromethyl)nicotinic acid, 97.0%, 5g

1-(2,3-Dihydro-1-benzofuran-5-yl)propan-1-one, 95%, 10g

Methyl 2-methoxy-5-methylbenzoate, 95.0%, 10g